How Can We Help?
Eli Lilly and Company v. Medtronic, Inc., 496 U.S. 661 (1990), is a United States Supreme Court case related to patent infringement in the medical device industry. It held that 35 U.S.C. § 271(e)(1)[1] of United States patent law exempted premarketing activity conducted to gain approval of a device under the Federal Food, Drug, and Cosmetic Act from a finding of infringement.[2]
See also
- Medtronic, Inc. v. Lohr (1996)
- Riegel v. Medtronic, Inc. (2008)
- List of United States Supreme Court cases, volume 496
References
External links
- Text of Eli Lilly & Co. v. Medtronic, Inc., 496 U.S. 661 (1990) is available from: Cornell CourtListener Google Scholar Justia Library of Congress Oyez (oral argument audio)
Recent Comments